NCT05651932 2026-02-10A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple MyelomaK36 Therapeutics, Inc.Phase 1 Recruiting125 enrolled
NCT06152575 2026-02-03MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)PfizerPhase 3 Recruiting492 enrolled